Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-10

Clinical Trial Update: Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)

View source ↗

Summary

A clinical trial update shows ongoing recruitment for the D-SHIELD study evaluating the effectiveness and safety of bulevirtide (BLV) in patients with chronic h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bulevirtide (bulevirtide)

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Hepatitis D | Status: RECRUITING